@article{464b0ef377f1411ca4aeade7ab96d880,
title = "Characterization of a putative orexin receptor in Ciona intestinalis sheds light on the evolution of the orexin/hypocretin system in chordates",
abstract = "Tunicates are evolutionary model organisms bridging the gap between vertebrates and invertebrates. A genomic sequence in Ciona intestinalis (CiOX) shows high similarity to vertebrate orexin receptors and protostome allatotropin receptors (ATR). Here, molecular phylogeny suggested that CiOX is divergent from ATRs and human orexin receptors (hOX1/2). However, CiOX appears closer to hOX1/2 than to ATR both in terms of sequence percent identity and in its modelled binding cavity, as suggested by molecular modelling. CiOX was heterologously expressed in a recombinant HEK293 cell system. Human orexins weakly but concentration-dependently activated its Gq signalling (Ca2+ elevation), and the responses were inhibited by the non-selective orexin receptor antagonists TCS 1102 and almorexant, but only weakly by the OX1-selective antagonist SB-334867. Furthermore, the 5-/6-carboxytetramethylrhodamine (TAMRA)-labelled human orexin-A was able to bind to CiOX. Database mining was used to predict a potential endogenous C. intestinalis orexin peptide (Ci-orexin-A). Ci-orexin-A was able to displace TAMRA-orexin-A, but not to induce any calcium response at the CiOX. Consequently, we suggested that the orexin signalling system is conserved in Ciona intestinalis, although the relevant peptide-receptor interaction was not fully elucidated.",
keywords = "Calcium, Ciona intestinalis, Hypocretin, Orexin, Receptor binding",
author = "Rinne, \{Maiju K.\} and Lauri Urvas and Ilona Mandrika and Dāvids Fridmanis and Riddy, \{Darren M.\} and Langmead, \{Christopher J.\} and Kukkonen, \{Jyrki P.\} and Henri Xhaard",
note = "Funding Information: This work was supported by the European Union (FP7-HEALTH-project GLORIA [\#602919]), the Magnus Ehrnrooth Foundation, the Liv \& H{\"a}lsa Foundation, Finska l{\"a}kares{\"a}llskapet, the Finnish Academy (SUDDEN project; decision 320210), and the Doctoral Program in Drug Research of the University of Helsinki. Funding Information: Santeri Suokas and Marja Peltola (Biochemistry and Cell Biology, Department of Veterinary Biosciences, University of Helsinki) are gratefully acknowledged for technical assistance with the experiments. Ance Roga (Latvian Biomedical Research and Study Centre) is gratefully acknowledged for help with the cloning. The cDNA of CiOX was provided by RIKEN BRC, which is participating in the National Bio-Resources Project of the MEXT, Japan, from the Ciona intestinalis Gene Collection I57 (RIKEN BRC collection RDB No. 6734-6743 NBRP Ciona EST clone No. citb011b12, GenBank sequence AK116539.1). Actelion as well as the current license owner Idorsia and licensee Neuropharmameds are gratefully acknowledged for the access to almorexant. The support of the European Cooperation in Science and Technology (COST) action through CA18133 ERNEST as well as the Doctoral Program in Drug Research of the University of Helsinki are gratefully acknowledged. The Biocenter Finland Drug Discovery and Chemical Biology consortium is thanked for providing access to computational resources (HX group). Funding Information: Santeri Suokas and Marja Peltola (Biochemistry and Cell Biology, Department of Veterinary Biosciences, University of Helsinki) are gratefully acknowledged for technical assistance with the experiments. Ance Roga (Latvian Biomedical Research and Study Centre) is gratefully acknowledged for help with the cloning. The cDNA of CiOX was provided by RIKEN BRC, which is participating in the National Bio-Resources Project of the MEXT, Japan, from the Ciona intestinalis Gene Collection I (RIKEN BRC collection RDB No. 6734-6743 NBRP Ciona EST clone No. citb011b12, GenBank sequence AK116539.1). Actelion as well as the current license owner Idorsia and licensee Neuropharmameds are gratefully acknowledged for the access to almorexant. The support of the European Cooperation in Science and Technology (COST) action through CA18133 ERNEST as well as the Doctoral Program in Drug Research of the University of Helsinki are gratefully acknowledged. The Biocenter Finland Drug Discovery and Chemical Biology consortium is thanked for providing access to computational resources (HX group). Publisher Copyright: {\textcopyright} The Author(s) 2024.",
year = "2024",
month = dec,
doi = "10.1038/s41598-024-56508-1",
language = "English",
volume = "14",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",
}